Method for detecting neutralizing antibody in coxsackievirus A6 (CV-A6), and recombinant virus applied in method

A technology of Coxsackie virus, group A, applied in the direction of virus/phage, biochemical equipment and method, virus, etc., can solve the problems of long time, large impact, cumbersome operation, etc., and achieve simple cost and easy operation. Effect

Active Publication Date: 2018-05-22
NAT INST FOR FOOD & DRUG CONTROL
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The result of this method is reliable, but the disadvantage is that the live virus is prone to antigenic drift during the passaging process, and more importantly, it is dangerous during the test operation, so the operation and safety equipment of te...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting neutralizing antibody in coxsackievirus A6 (CV-A6), and recombinant virus applied in method
  • Method for detecting neutralizing antibody in coxsackievirus A6 (CV-A6), and recombinant virus applied in method
  • Method for detecting neutralizing antibody in coxsackievirus A6 (CV-A6), and recombinant virus applied in method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Embodiment 1, detection of enterovirus CV-A6 neutralizing antibody detection

[0053] 1. Construction of CV-A6 nucleocapsid protein expression plasmid and CV-A16 replicon plasmid

[0054] (1) Construct CV-A6 nucleocapsid protein expression plasmid

[0055] Using the full-length infectious cloning plasmid of CV-A6 as a template, the structural protein coding segment of CV-A6 (including VP4, VP2, VP3, VP1) was obtained by PCR amplification, and green fluorescent protein (GFP) was inserted into the N-terminal of the viral genome structural protein ( EGFP) gene. The gene sequence of EGFP was spliced ​​with the gene sequence of all structural proteins of CV-A6, and the restriction site of 2A protease was inserted into the C-terminus of the EGFP gene, and spliced ​​to obtain the fusion gene ( figure 1 B), its nucleotide sequence is shown in SEQ ID No.2, wherein the 1st to 717th is the coding gene of green fluorescent protein (the amino acid sequence of green fluorescent pro...

Embodiment 2

[0081] Embodiment two, check the consistency of the method of the present invention and classical live virus neutralization test

[0082] In parallel, the neutralizing antibody titer of a group of human plasma samples was tested with the wild-type CV-A6 live virus and the CV-A6 pseudovirus of the present invention. The wild-type CV-A6 virus strain is CV-A6-2014-XM, and the test sample comes from the phase III clinical serum sample of EV-A71 vaccine (from the China Institute for Food and Drug Control). Correlation analysis was performed on the two groups of test results, such as figure 2 As shown, the results show that the pseudovirus system of the present invention has good consistency with the classic live virus neutralization test when detecting serum neutralizing antibodies.

Embodiment 3

[0083] Embodiment three, test the specificity of CV-A6 pseudovirus system

[0084] In order to test the specificity of the CV-A6 pseudovirus system, a mouse-derived specific antiserum against CV-A6 (serum from SPF grade BALB / c mice immunized with CV-A6(XM) inactivated virus ), mouse-derived specific antiserum against EV-A71 (FY) (from the serum of SPF grade BALB / c mice immunized with EV-A71 (FY) inactivated virus), mouse-derived specific antiserum against CV -B3(112)-specific antiserum (serum from SPF-grade BALB / c mice immunized with CV-B3(112) inactivated virus), mouse-derived specific for CV-A16(G10) Antiserum (from SPF grade BALB / c mice immunized with CV-A16(G10) inactivated virus), mouse-derived specific antiserum against CV-B5(417) (from CV-B5 (417) The serum of SPF level BALB / c mice immunized with inactivated virus) and mouse-derived specific antiserum against hepatitis E HEV (from the hepatitis E vaccine immunized with the Hepatitis E vaccine produced by Wantai Canghai...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for detecting a neutralizing antibody in coxsackievirus A6 (CV-A6), and a recombinant virus applied in the method. According to the method, the neutralizing antibody is detected by using a pseudovirus system packaged by two types of recombinant plasmids; by adopting a single-cycle infected pseudovirus, the safety problem caused by use of live viruses is avoided. The results of a plurality of tests prove that the pseudovirus detection system is a CV-A6 neutralizing antibody detection method which is safe, sensitive, rapid, specific, simple and convenient, and low in cost. Based on the characteristics, the pseudovirus detection system is very suitable for the tests for rapid and large-scale detection of the neutralizing antibody, and has an import applicationvalue for development of a CV-A6 viral vaccine and detection of CV-A6 specific neutralizing antibody level of patients and populations.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular to a detection method for detecting coxsackievirus group A type 6 neutralizing antibodies and a special pseudovirus thereof, in particular to two recombinant plasmids for packaging special pseudoviruses, a method for preparing the plasmid, Special pseudovirus and rapid detection kit. Background technique: [0002] Coxsackievirus group A type 6 (Coxsackievirus A6, CV-A6) belongs to the genus Enterovirus of the family Picornaviridae. CV-A6 is a single-stranded positive-strand RNA virus. The virus particle is a spherical structure with icosahedral stereosymmetry, about 30 mm in diameter, without envelope and protrusions. The total length of the CV-A6 genome is about 7400bp, and the genome consists of an open reading frame and two non-coding regions (5'-UTR and 3'-UTR). The open reading frame is a polyprotein consisting of 2202 amino acids, which is further hydrolyzed into 3 precursor pro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/63C12N15/65C12N7/01G01N33/569
CPCC12N7/00C12N15/63C12N15/65C12N2770/32321G01N33/56983G01N2469/20
Inventor 吴星苏瑶梁争论陈盼董方玉孙世洋毛群颖高帆卞莲莲姜崴胡亚林
Owner NAT INST FOR FOOD & DRUG CONTROL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap